Angélica Espinosa Miranda

Angélica Espinosa Miranda

Auto-generated profile, based on publicly available information

Angélica Espinosa Miranda

Universidade Federal do Espirito Santo

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LFLuciana Bueno Freitas
Luciana Bueno Freitas
ZCZigui Chen
Zigui Chen
EMElaine Freire Muqui
Elaine Freire Muqui
NBNeide Aparecida Tosato Boldrini
Neide Aparecida Tosato Boldrini
AMAngélica Espinosa Miranda
Angélica Espinosa Miranda
RBRobert D. Burk
Robert D. Burk
HPV16 accounts for 50–70% of cervical cancer cases worldwide. Characterization of HPV16 variants previously indicated that they differ in risks for viral persistence, progression to cervical precancer and malignant cancer. The aim of this study was to examine the association of severity of disease with HPV16 variants identified in specimens (n = 281) obtained from a Cervical Pathology and Colposcopy outpatient clinic in the University Hospital of Espírito Santo State, Southeastern Brazil, from April 2010 to November 2011. All cytologic and histologic diagnoses were determined prior to definitive treatment. The DNA was isolated using QIAamp DNA Mini Kit and HPV was detected by amplification with PGMY09/11 primers and positive samples were genotyped by RFLP analyses and reverse line blot. The genomes of the HPV16 positive samples were sequenced, from which variant lineages were determined. Chi2 statistics was performed to test the association of HPV16 variants between case and control groups. The prevalence of HR-HPV types in <CIN1, CIN2 and CIN3+ were 33.7%, 84.4% and 91.6%, respectively. Thirty-eight of 49 (78%) HPV16 positive samples yielded HPV16 sequence information; of which, 32 complete genomes were sequenced and an additional 6 samples were partially sequenced. Phylogenetic analysis and patterns of variations identified 65.8% (n = 25) as HPV16 European (E) and 34.2% (n = 13) as non-European (NE) variants. Classification of disease into CIN3+ vs. <CIN3 indicated that NE types were associated with high-grade disease with an OR = 4.6 (1.07–20.2, p = 0.05). The association of HPV16 NE variants with an increased risk of CIN3+ is consistent with an HPV16 genetically determined enhanced oncogenicity. The prevalence of genetic variants of HPV16 is distributed across different geographical areas and with recent population admixture, only empiric data will provide information on the highest risk HPV16 variants within a given population.

1 January 2010 in Jornal Brasileiro de Psiquiatria
Verified
Journal Article
Open access
PDF file
KFKaroline Pedroti Fiorotti
Karoline Pedroti Fiorotti
RRRenzo Roldi Rossoni
Renzo Roldi Rossoni
LBLuiz Henrique Borges
Luiz Henrique Borges
AMAngélica Espinosa Miranda
Angélica Espinosa Miranda
Objetivo: O objetivo do estudo foi estimar a prevalência de transtornos mentais comuns (TMC) entre os estudantes do curso de medicina da UFES e avaliar possíveis correlações entre TMC e fatores de risco. Métodos: Estudo transversal realizado de setembro a novembro de 2007 envolvendo 229 alunos do curso de medicina. O questionário utilizado foi autoaplicável e anônimo. Foram coletados dados socioeconômicos, informações sobre o curso, o processo de ensino-aprendizagem e a rede de apoio social. Para o rastreamento de TMC, utilizou-se o Self-Reporting Questionnaire (SRQ-20). Resultados: A prevalência total de TMC encontrada foi de 37,1% (IC 95%, 30,8%-43,4%), que esteve independentemente associada a não receber o apoio emocional necessário (OR = 7,4, IC 95%, 3,1-17,9) e relatar "dificuldade para tirar dúvidas em sala de aula por timidez" durante a infância ou adolescência (OR = 2,5, IC 95%, 1,0-6,1). Conclusão: Os dados demonstram elevada prevalência de TMC nessa população e a importância em subsidiar ações para prevenção e cuidado com a saúde mental dos estudantes, melhorando a qualidade de vida deles.

24 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AFAllex Jardim Fonseca
Allex Jardim Fonseca
DTDaniela Taeko
Daniela Taeko
TCThiciane Araújo Chaves
Thiciane Araújo Chaves
LALucia Dayanny da Costa Amorim
Lucia Dayanny da Costa Amorim
RMRaisa Saron Wanderley Murari
Raisa Saron Wanderley Murari
LFLuiz Carlos Lima Ferreira
Luiz Carlos Lima Ferreira
Indigenous women from the Amazon regions have some of the highest rates of cervical cancer in the world. This study evaluated cervical cytology and human papillomavirus (HPV) in native women that differ by lifestyle and interaction with western society. Yanomami women are isolated deep in the Amazon with a hunter/gatherer lifestyle. Macuxi and Wapishana women live in proximity to western society. To select a representative group of women from each district, random cluster sampling was used, considering each registered village as a cluster. Cervical samples were collected for cytology and HPV detection and typing by PCR amplification and next generation sequencing. The study was approved by the National IRB and by tribal leaders. 664 native women were enrolled from 13 indigenous villages (76% participation rate). Yanomami women had higher rates of abnormal cytology (5.1% vs. 1.8%, p = 0.04) and prevalent HR-HPV (34.1% vs. 19.2%, p35y of age were significantly more likely to have HR-HPV, whereas women ≤35y did not significantly differ between groups. Prevalence of HPV was significantly different amongst geographically clustered Yanomami women (p<0.004). The most prevalent HPV types in the entire group were HPV31 (8.7%), HPV16 (5.9%) and HPV18 (4.4%). Isolated endogenous Yanomami women were more likely to be HPV+ and rates increased with age. Study of HPV in isolated hunter-gather peoples suggests that long-term persistence is a characteristic of prehistoric humans and patterns reflecting decreased prevalence with age in western society represents recent change. These studies have implications for cervical cancer prevention and viral-host relationships.

1 October 2011 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
VPValdir Monteiro Pinto
Valdir Monteiro Pinto
CSCélia Landmann Szwarcwald
Célia Landmann Szwarcwald
CBCarla Baroni
Carla Baroni
LSLorenzo Lyrio Stringari
Lorenzo Lyrio Stringari
LILilian Amaral Inocêncio
Lilian Amaral Inocêncio
AMAngélica Espinosa Miranda
Angélica Espinosa Miranda
Chlamydia trachomatis (CT) is a sexually transmitted infection having repercussions on reproductive health and impact on the fotus. Our goal was to estimate the prevalence of and risk factors for CT in young parturient women in Brazil. A national cross-sectional study of parturient women, aged 15 to 24 years, attending Brazilian public hospitals was performed in 2009. Participants answered a questionnaire including demographic, behavioral, and clinical data. A sample of urine was collected and screened for CT and Neisseria gonorrhoeae (NG), using polymerase chain reaction COBAS Amplicor CT/NG (Roche Molecular Systems, Branchburg, NJ). A total of 2400 women were selected and 2071 (86.3%) participated in the study. Mean age was 20.2 years (standard deviation = 2.7). Prevalence rates of CT and NG were 9.8% (95% confidence interval [CI]: 8.5–11.1) and 1.0% (95% CI: 0.6%–1.4%), respectively. Four percent of women infected with CT also had NG infection. CT associated factors were: being younger (15–19 years old) (odds ratio [OR] = 1.6 [95% CI: 1.15–2.17]); first sexual intercourse before 15 years of age (OR = 1.4 [95% CI: 1.04–6.24]); having more than 1 sexual partner in lifetime (OR = 1.6 [95% CI: 1.13–2.26]); Pap smear screening more than 1 year (OR = 1.5 [95% CI: 1.08–2.05]); and NG infection (OR = 7.6 [95% CI: 3.05–19.08]). This study shows a high prevalence of CT infection among young pregnant women in Brazil. We suggest that CT screening should be included as part of antenatal care routine in this group in Brazil.

24 April 2023 in JHEP Reports
Verified
Journal Article
Open access
PMPhilippa C. Matthews
Philippa C. Matthews
POPonsiano Ocama
Ponsiano Ocama
SWSu Wang
Su Wang
MEManal El-Sayed
Manal El-Sayed
ATAnna Turkova
Anna Turkova
SHSaeed Hamid
Saeed Hamid
Prevention of mother-to-child transmission of hepatitis B virus (HBV) infection is a cornerstone of efforts to support progress towards elimination of viral hepatitis. Current guidelines recommend maternal screening, antiviral therapy during the third trimester of high-risk pregnancies, universal and timely HBV birth dose vaccination, and post-exposure prophylaxis with hepatitis B immunoglobulin for selected neonates. However, serological and molecular diagnostic testing, treatment and HBV vaccination are not consistently deployed, particularly in many high endemicity settings, and models predict that global targets for reduction in paediatric incidence will not be met by 2030. In this article, we briefly summarise the evidence for current practice and use this as a basis to discuss areas in which prevention of mother-to-child transmission can potentially be enhanced. By reducing health inequities, enhancing pragmatic use of resources, filling data gaps, developing advocacy and education, and seeking consistent investment from multilateral agencies, significant advances can be made to further reduce vertical transmission events, with wide health, societal and economic benefits.

1 January 2021 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
FFFrancisca Lidiane Sampaio Freitas
Francisca Lidiane Sampaio Freitas
ABAdele Schwartz Benzaken
Adele Schwartz Benzaken
MPMauro Romero Leal de Passos
Mauro Romero Leal de Passos
ICIvo Castelo Branco Coelho
Ivo Castelo Branco Coelho
AMAngélica Espinosa Miranda
Angélica Espinosa Miranda
Resumo O Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis, publicado pelo Ministério da Saúde do Brasil em 2020, contempla a atualização sobre sífilis adquirida. O documento apresenta a utilização de testes rápidos, a segurança e a eficácia da administração da benzilpenicilina benzatina, o seguimento dos casos, o manejo clínico e laboratorial da neurossífilis, a abordagem de parcerias sexuais, a assistência e o acompanhamento de gestantes diagnosticadas e as especificidades da coinfecção sífilis e HIV, além de uma síntese sobre a notificação dos casos. É necessário capacitar gestores e profissionais de saúde de forma contínua, com vistas à integração entre assistência e vigilância, ao fortalecimento de ações efetivas de controle da sífilis, à abrangência da busca de parcerias sexuais e ao amplo acesso de populações mais vulneráveis aos serviços de saúde.